Literature DB >> 33603076

Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults.

Rong Xu1,2, Renfei Lu3, Tao Zhang4, Qunfu Wu4, Weihua Cai3, Xudong Han3, Zhenzhou Wan5, Xia Jin6, Zhigang Zhang7, Chiyu Zhang8,9.   

Abstract

SARS-CoV-2 is the cause of COVID-19. It infects multiple organs including the respiratory tract and gut. Dynamic changes of regional microbiomes in infected adults are largely unknown. Here, we performed longitudinal analyses of throat and anal swabs from 35 COVID-19 and 19 healthy adult controls, as well as 10 non-COVID-19 patients with other diseases, by 16 S rRNA gene sequencing. The results showed a partitioning of the patients into 3-4 categories based on microbial community types (I-IV) in both sites. The bacterial diversity was lower in COVID-19 patients than healthy controls and decreased gradually from community type I to III/IV. Although the dynamic change of microbiome was complex during COVID-19, a synchronous restoration of both the upper respiratory and gut microbiomes from early dysbiosis towards late more diverse status was observed in 6/8 mild COVID-19 adult patients. These findings reveal previously unknown interactions between upper respiratory and gut microbiomes during COVID-19.

Entities:  

Year:  2021        PMID: 33603076     DOI: 10.1038/s42003-021-01796-w

Source DB:  PubMed          Journal:  Commun Biol        ISSN: 2399-3642


  53 in total

Review 1.  Relationship between nasopharyngeal microbiota and patient's susceptibility to viral infection.

Authors:  Grégory Dubourg; Sophie Edouard; Didier Raoult
Journal:  Expert Rev Anti Infect Ther       Date:  2019-05-29       Impact factor: 5.091

Review 2.  The microbiota in adaptive immune homeostasis and disease.

Authors:  Kenya Honda; Dan R Littman
Journal:  Nature       Date:  2016-07-07       Impact factor: 49.962

3.  Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection.

Authors:  Wouter A A de Steenhuijsen Piters; Santtu Heinonen; Raiza Hasrat; Eleonora Bunsow; Bennett Smith; Maria-Carmen Suarez-Arrabal; Damien Chaussabel; Daniel M Cohen; Elisabeth A M Sanders; Octavio Ramilo; Debby Bogaert; Asuncion Mejias
Journal:  Am J Respir Crit Care Med       Date:  2016-11-01       Impact factor: 21.405

4.  Characterization of two new electrophoretic variants of human triosephosphate isomerase: stability, kinetic, and immunological properties.

Authors:  J Asakawa; H W Mohrenweiser
Journal:  Biochem Genet       Date:  1982-02       Impact factor: 1.890

5.  Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge.

Authors:  E Kaitlynn Allen; Alex F Koeppel; J Owen Hendley; Stephen D Turner; Birgit Winther; Michèle M Sale
Journal:  Microbiome       Date:  2014-06-25       Impact factor: 14.650

6.  Distinct Nasopharyngeal and Oropharyngeal Microbiota of Children with Influenza A Virus Compared with Healthy Children.

Authors:  Zhixin Wen; Gan Xie; Qian Zhou; Chuangzhao Qiu; Jing Li; Qian Hu; Wenkui Dai; Dongfang Li; Yuejie Zheng; Feiqiu Wen
Journal:  Biomed Res Int       Date:  2018-11-19       Impact factor: 3.411

7.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

Review 8.  The microbiota of the respiratory tract: gatekeeper to respiratory health.

Authors:  Wing Ho Man; Wouter A A de Steenhuijsen Piters; Debby Bogaert
Journal:  Nat Rev Microbiol       Date:  2017-03-20       Impact factor: 60.633

9.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

10.  Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding.

Authors:  Yi Xu; Xufang Li; Bing Zhu; Huiying Liang; Chunxiao Fang; Yu Gong; Qiaozhi Guo; Xin Sun; Danyang Zhao; Jun Shen; Huayan Zhang; Hongsheng Liu; Huimin Xia; Jinling Tang; Kang Zhang; Sitang Gong
Journal:  Nat Med       Date:  2020-03-13       Impact factor: 87.241

View more
  24 in total

1.  Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients.

Authors:  Tian Qin; Yajie Wang; Jianping Deng; BaoHong Xu; Xiong Zhu; Jitao Wang; Haijian Zhou; Na Zhao; Fangfang Jin; Hongyu Ren; Huizhu Wang; Qun Li; Xinmin Xu; Yumei Guo; Ruihong Li; Yanwen Xiong; XiaoXia Wang; Jiane Guo; Han Zheng; Xuexin Hou; Kanglin Wan; Jianzhong Zhang; Jinxing Lu; Biao Kan; Jianguo Xu
Journal:  Microbiol Spectr       Date:  2022-05-17

Review 2.  Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications.

Authors:  Raphaela I Lau; Fen Zhang; Qin Liu; Qi Su; Francis K L Chan; Siew C Ng
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-10-21       Impact factor: 73.082

3.  Respiratory tract infections and gut microbiome modifications: A systematic review.

Authors:  Claire A Woodall; Luke J McGeoch; Alastair D Hay; Ashley Hammond
Journal:  PLoS One       Date:  2022-01-13       Impact factor: 3.240

Review 4.  Potential Associations Between Microbiome and COVID-19.

Authors:  Huifen Wang; Haiyu Wang; Ying Sun; Zhigang Ren; Weiwei Zhu; Ang Li; Guangying Cui
Journal:  Front Med (Lausanne)       Date:  2021-12-22

Review 5.  Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review.

Authors:  Tik Fung Dave Liu; Elena Philippou; Ourania Kolokotroni; Georgios Siakallis; Kenan Rahima; Constantina Constantinou
Journal:  Infection       Date:  2021-10-20       Impact factor: 7.455

Review 6.  Bioengineered angiotensin-converting-enzyme-2: a potential therapeutic option against SARS-CoV-2 infection.

Authors:  Biplab K Maiti
Journal:  J Hum Hypertens       Date:  2021-11-12       Impact factor: 2.877

Review 7.  Importance of gut microbiome regulation for the prevention and recovery process after SARS-CoV-2 respiratory viral infection (Review).

Authors:  Nuroh Najmi; Imam Megantara; Lovita Andriani; Hanna Goenawan; Ronny Lesmana
Journal:  Biomed Rep       Date:  2022-02-14

8.  Dynamics of the Upper Respiratory Tract Microbiota and Its Association with Mortality in COVID-19.

Authors:  Lili Ren; Yeming Wang; Jiaxin Zhong; Xia Li; Yan Xiao; Jie Li; Jing Yang; Guohui Fan; Li Guo; Zijie Shen; Lu Kang; Leisheng Shi; Qiong Li; Jizhou Li; Lin Di; Haibo Li; Conghui Wang; Ying Wang; Xinming Wang; Xiaohui Zou; Jian Rao; Li Zhang; Jianbin Wang; Yanyi Huang; Bin Cao; Jianwei Wang; Mingkun Li
Journal:  Am J Respir Crit Care Med       Date:  2021-12-15       Impact factor: 21.405

9.  Progressive deterioration of the upper respiratory tract and the gut microbiomes in children during the early infection stages of COVID-19.

Authors:  Rong Xu; Pengcheng Liu; Tao Zhang; Qunfu Wu; Mei Zeng; Yingying Ma; Xia Jin; Jin Xu; Zhigang Zhang; Chiyu Zhang
Journal:  J Genet Genomics       Date:  2021-05-29       Impact factor: 4.275

10.  Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19.

Authors:  Jing Liu; Sheng Liu; Zhao Zhang; Xuejun Lee; Wenxuan Wu; Zhanlian Huang; Ziying Lei; Wenxiong Xu; Dabiao Chen; Xing Wu; Yang Guo; Liang Peng; Bingliang Lin; Yutian Chong; Xiangyu Mou; Mang Shi; Ping Lan; Tao Chen; Wenjing Zhao; Zhiliang Gao
Journal:  Synth Syst Biotechnol       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.